Opto Circuits rallies as company gets USFDA clearance to market new AED

MUMBAI: Shares of Opto Circuits surged as much as 14.21 per cent in intraday trade after its group company Cardiac Science Corporation got market clearance from the USFDA to market its Powerheart G5 automated external defibrillators (AED) with CPRD.

The Powerheart family of AEDs enables rescuers to swiftly provide life-saving therapy to aid a person who has suffered sudden cardiac arrest.

Powerheart G5 AED with CPRD will be available for purchase in the US later this year.